PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
70.15
-1.32 (-1.85%)
At close: May 18, 2026, 4:00 PM EDT
70.05
-0.10 (-0.14%)
Pre-market: May 19, 2026, 4:40 AM EDT
PTC Therapeutics Employees
PTC Therapeutics had 991 employees as of December 31, 2025. The number of employees increased by 52 or 5.54% compared to the previous year.
Employees
991
Change (1Y)
52
Growth (1Y)
5.54%
Revenue / Employee
$834,622
Profits / Employee
-$188,423
Market Cap
5.82B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 991 | 52 | 5.54% | 991 | 0 |
| Dec 31, 2024 | 939 | -116 | -11.00% | 939 | 0 |
| Dec 31, 2023 | 1,055 | -355 | -25.18% | 988 | 67 |
| Dec 31, 2022 | 1,410 | 233 | 19.80% | 1,402 | 8 |
| Dec 31, 2021 | 1,177 | 210 | 21.72% | 1,167 | 10 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Corcept Therapeutics | 730 |
| Mirum Pharmaceuticals | 418 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Immunovant | 362 |
| Scholar Rock Holding | 289 |
| Apogee Therapeutics | 261 |
| Cogent Biosciences | 258 |
PTCT News
- 6 days ago - PTC Therapeutics Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 7 days ago - PTC Therapeutics price target raised to $89 from $80 at JPMorgan - TheFly
- 10 days ago - PTC Therapeutics price target raised to $94 from $92 at Morgan Stanley - TheFly
- 11 days ago - PTC Therapeutics upgraded to Buy from Hold at TD Cowen - TheFly
- 11 days ago - PTC Therapeutics reports Q1 EPS (3c) vs. ($10.04) last year - TheFly
- 11 days ago - PTC Therapeutics raises 2026 revenue view to $1.08B-$1.18B, consensus $990.78M - TheFly
- 11 days ago - PTC Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 11 days ago - PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results - PRNewsWire